BIOCORP Announces The CE IIb Approval of Its Mallya Device

100

ISSOIRE, France–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/digitalhealth?src=hash" target="_blank">#digitalhealth</a>–Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / PEA‐PME eligible), French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, today announces that Mallya has obtained the CE 0459 mark as medical device class IIb. Mallya is a smart sensor that turns conventional insulin pens into connected devices. Mallya records the key treatment information (selected dose, date and time of injection) and http://www.businesswire.com/news/home/20190612005727/en/BIOCORP-Announces-CE-IIb-Approval-Mallya-Device/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==